I
119THCONGRESS
1
STSESSION H. R. 1300
To amend title XXVII of the Public Health Service Act to require group
health plans and health insurance issuers offering group or individual
health insurance coverage to provide coverage for prostate cancer
screenings without the imposition of cost-sharing requirements, and for
other purposes.
IN THE HOUSE OF REPRESENTATIVES
FEBRUARY13, 2025
Mr. D
UNNof Florida (for himself, Ms. CLARKEof New York, Mr. MURPHY,
and Mr. C
ARTERof Louisiana) introduced the following bill; which was
referred to the Committee on Energy and Commerce
A BILL
To amend title XXVII of the Public Health Service Act
to require group health plans and health insurance
issuers offering group or individual health insurance cov-
erage to provide coverage for prostate cancer screenings
without the imposition of cost-sharing requirements, and
for other purposes.
Be it enacted by the Senate and House of Representa-1
tives of the United States of America in Congress assembled, 2
VerDate Sep 11 2014 01:36 Mar 11, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H1300.IH H1300
kjohnson on DSK7ZCZBW3PROD with $$_JOB 2
•HR 1300 IH
SECTION 1. SHORT TITLE. 1
This Act may be cited as the ‘‘Prostate-Specific Anti-2
gen Screening for High-risk Insured Men Act’’ or the 3
‘‘PSA Screening for HIM Act’’. 4
SEC. 2. FINDINGS. 5
Congress finds the following: 6
(1) Prostate cancer is the second leading cause 7
of cancer death in men in the United States with 1 8
in 44 men dying from prostate cancer and more 9
than 35,700 men estimated to die from prostate 10
cancer in 2025. 11
(2) Prostate cancer is the second most com-12
monly diagnosed cancer in the Nation with 1 in 8 13
men being diagnosed in their lifetimes, 3.3 million 14
men in the United States living with a diagnosis, 15
and over 310,000 men estimated to be diagnosed in 16
2025. 17
(3) The survival rate for prostate cancer diag-18
nosed in early stage is near 100 percent but prostate 19
cancer diagnosed in late stage has only a 37 percent 20
survival rate. 21
(4) There are few, if any, symptoms of prostate 22
cancer before it reaches late stage. 23
(5) African-American men have a disproportion-24
ately higher rate of prostate cancer and are 70 per-25
cent more likely to be diagnosed with prostate can-26
VerDate Sep 11 2014 01:36 Mar 11, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H1300.IH H1300
kjohnson on DSK7ZCZBW3PROD with $$_JOB 3
•HR 1300 IH
cer than White men, with 1 in 6 African-American 1
men developing prostate cancer in their lifetimes. 2
(6) African-American men are 2.1 times more 3
likely to die from prostate cancer than White men. 4
(7) Men with a father or brother with prostate 5
cancer are more than twice as likely to be diagnosed 6
with prostate cancer than men without a family his-7
tory. 8
(8) The common clinical definition for men at 9
high-risk of prostate cancer includes African-Amer-10
ican men and men with a family history. 11
(9) Most of the major cancer and urological so-12
cieties recommend beginning screening discussions 13
earlier for African-American men and those with a 14
family history of prostate cancer. 15
(10) The United States Preventive Services 16
Task Force has encouraged research on screening 17
African-American men, including whether to screen 18
African-American men at younger ages, and has 19
identified this research as a high-priority cancer re-20
search gap. 21
(11) Barriers to screening should be minimized 22
for high-risk men in order to catch asymptomatic 23
prostate cancer before it metastasizes and the sur-24
vival rate is dramatically reduced. 25
VerDate Sep 11 2014 01:36 Mar 11, 2025 Jkt 059200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H1300.IH H1300
kjohnson on DSK7ZCZBW3PROD with $$_JOB 4
•HR 1300 IH
(12) The cost of treating metastatic prostate 1
cancer in the United States health care system is 2
hundreds of millions of dollars more annually than 3
the cost of treating localized, early-stage cancer. 4
SEC. 3. REQUIREMENT FOR GROUP HEALTH PLANS AND 5
HEALTH INSURANCE ISSUERS OFFERING 6
GROUP OR INDIVIDUAL HEALTH INSURANCE 7
COVERAGE TO PROVIDE COVERAGE FOR 8
PROSTATE CANCER SCREENINGS WITHOUT 9
IMPOSITION OF COST-SHARING REQUIRE-10
MENTS. 11
(a) I
NGENERAL.—Subsection (a) of section 2713 of 12
the Public Health Service Act (42 U.S.C. 300gg–13) is 13
amended to read as follows: 14
‘‘(a) C
OVERAGE OF PREVENTIVEHEALTHSERV-15
ICES.— 16
‘‘(1) I
N GENERAL.—A group health plan and a 17
health insurance issuer offering group or individual 18
health insurance coverage shall, at a minimum, pro-19
vide coverage for and shall not impose any cost-shar-20
ing requirements for— 21
‘‘(A) evidence-based items or services that 22
have in effect a rating of ‘A’ or ‘B’ in the cur-23
rent recommendations of the United States Pre-24
ventive Services Task Force; 25
VerDate Sep 11 2014 01:36 Mar 11, 2025 Jkt 059200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\H1300.IH H1300
kjohnson on DSK7ZCZBW3PROD with $$_JOB 5
•HR 1300 IH
‘‘(B) immunizations that have in effect a 1
recommendation from the Advisory Committee 2
on Immunization Practices of the Centers for 3
Disease Control and Prevention with respect to 4
the individual involved; 5
‘‘(C) with respect to infants, children, and 6
adolescents, evidence-informed preventive care 7
and screenings provided for in the comprehen-8
sive guidelines supported by the Health Re-9
sources and Services Administration; 10
‘‘(D) with respect to women, such addi-11
tional preventive care and screenings not de-12
scribed in subparagraph (A) as provided for in 13
comprehensive guidelines supported by the 14
Health Resources and Services Administration 15
for purposes of this subparagraph; and 16
‘‘(E) with respect to men who are age 40 17
and over and are at high risk of developing 18
prostate cancer (including African-American 19
men and men with a family history of prostate 20
cancer (as defined in paragraph (2))), such ad-21
ditional evidence-based preventive care and 22
screenings not described in subparagraph (A) 23
for prostate cancer. 24
VerDate Sep 11 2014 01:36 Mar 11, 2025 Jkt 059200 PO 00000 Frm 00005 Fmt 6652 Sfmt 6201 E:\BILLS\H1300.IH H1300
kjohnson on DSK7ZCZBW3PROD with $$_JOB 6
•HR 1300 IH
‘‘(2) MEN WITH A FAMILY HISTORY OF PROS -1
TATE CANCER DEFINED .—For purposes of para-2
graph (1)(E), the term ‘men with a family history 3
of prostate cancer’ means men who have a first-de-4
gree relative— 5
‘‘(A) who was diagnosed with prostate can-6
cer; 7
‘‘(B) who developed prostate cancer; 8
‘‘(C) whose death was a result of prostate 9
cancer; 10
‘‘(D) who have been diagnosed with a can-11
cer known to be associated with increased risk 12
of prostate cancer; or 13
‘‘(E) who has a genetic alteration known to 14
be associated with increased risk of prostate 15
cancer. 16
‘‘(3) C
LARIFICATION REGARDING BREAST CAN -17
CER SCREENING, MAMMOGRAPHY, AND PREVENTION 18
RECOMMENDATIONS .—For the purposes of this Act, 19
and for the purposes of any other provision of law, 20
the current recommendations of the United States 21
Preventive Service Task Force regarding breast can-22
cer screening, mammography, and prevention shall 23
be considered the most current other than those 24
issued in or around November 2009. 25
VerDate Sep 11 2014 01:36 Mar 11, 2025 Jkt 059200 PO 00000 Frm 00006 Fmt 6652 Sfmt 6201 E:\BILLS\H1300.IH H1300
kjohnson on DSK7ZCZBW3PROD with $$_JOB 7
•HR 1300 IH
‘‘(4) RULE OF CONSTRUCTION .—Nothing in 1
this subsection shall be construed to prohibit a plan 2
or issuer from providing coverage for services in ad-3
dition to those recommended by the United States 4
Preventive Services Task Force or to deny coverage 5
for services that are not recommended by such Task 6
Force.’’. 7
(b) E
FFECTIVEDATE.—The amendment made by 8
subsection (a) shall apply with respect to plan years begin-9
ning on or after January 1, 2026. 10
Æ
VerDate Sep 11 2014 01:36 Mar 11, 2025 Jkt 059200 PO 00000 Frm 00007 Fmt 6652 Sfmt 6301 E:\BILLS\H1300.IH H1300
kjohnson on DSK7ZCZBW3PROD with $$_JOB